John Magnette
Impact in
-
- Smoking Behavior and Cessation
-
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Rolf Weitkunat (3 shared papers)Frank Lüdicke (3 shared papers)Pierre R Bechtel (6 shared papers)Gizelle S. Baker (2 shared papers)Patrick Picavet (1 shared paper)Nicole Poisson (1 shared paper)Catherine Bonaïti‐Pellié (1 shared paper)Christelle Haziza (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (3 papers)Nicotine & Tobacco Research (2 papers)British Journal of Clinical Pharmacology (1 paper)Regulatory Toxicology and Pharmacology (1 paper)Biomarkers (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
John Magnette
16 papers receiving 301 citations
Peers
Comparison fields: 5 of 75
- Physiology 126
- Pharmacology 27
- Internal Medicine 10
- Statistics and Probability 23
- Health, Toxicology and Mutagenesis 27
Countries citing papers authored by John Magnette
This map shows the geographic impact of John Magnette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Magnette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Magnette more than expected).
Fields of papers citing papers by John Magnette
This network shows the impact of papers produced by John Magnette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Magnette. The network helps show where John Magnette may publish in the future.
Co-authors
The 25 scholars most cited alongside John Magnette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 53 | |
| 2 | 1993 | 46 | |
| 3 | 2012 | 35 | |
| 4 | 2016 | 32 | |
| 5 | 1996 | 20 | |
| 6 | 2015 | 20 | |
| 7 | 1991 | 20 | |
| 8 | Cinchonine per os: efficient circumvention of P-glycoprotein-mediated multidrug resistance. | 1995 | 19 |
| 9 | 1998 | 17 | |
| 10 | 2005 | 17 | |
| 11 | Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study. | 2001 | 13 |
| 12 | The efficacy and safety of low-dose diclofenac sodium 0.1% gel for the symptomatic relief of pain and erythema associated with superficial natural sunburn. | 2004 | 11 |
| 13 | 1995 | 7 | |
| 14 | 1994 | 5 | |
| 15 | 2004 | 4 | |
| 16 | 1996 | 3 |
About John Magnette
John Magnette is a scholar working on Pharmacology, Oncology, Dermatology, Physiology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 322 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Smoking Behavior and Cessation (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Skin Protection and Aging (2 papers), Photodynamic Therapy Research Studies (2 papers), Acne and Rosacea Treatments and Effects (1 paper) and Glycogen Storage Diseases and Myoclonus (1 paper). The work is most often cited by research in Physiology (126 citations), Pharmacology (27 citations), Internal Medicine (10 citations), Statistics and Probability (23 citations) and Health, Toxicology and Mutagenesis (27 citations). John Magnette has collaborated with scholars based in France and Switzerland. Frequent co-authors include Rolf Weitkunat, Frank Lüdicke, Pierre R Bechtel, Gizelle S. Baker, Patrick Picavet, Nicole Poisson, Catherine Bonaïti‐Pellié, Christelle Haziza, Claire Martin Leroy and Agnieszka Kulesza. Their work appears in journals such as European Journal of Clinical Pharmacology, Nicotine & Tobacco Research, British Journal of Clinical Pharmacology, Regulatory Toxicology and Pharmacology and Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.